LA Times Columnist Targets CIRM; Structural Changes Needed
The California stem cell agency, which has “self-righteously” opposed better public oversight of its activities, should be altered to create a research program that “exemplifies not only good science, but good government,” a Pulitzer Prize-winning columnist said today in the Los Angeles Times.
While noting that the agency has funded “important work,” Mic…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.